{"id":"W2603579700","doi":"10.1200/jco.2009.27.15_suppl.8045","title":"Efficacy of pemetrexed-cisplatin (PC) in East Asian patients (pts): Subgroup analysis of a phase III study comparing PC versus gemcitabine-cisplatin (GC) in first-line treatment of advanced non-small cell lung cancer (NSCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Internal medicine; Pemetrexed; Oncology; Hazard ratio; Gemcitabine; Population; Subgroup analysis; Chemotherapy; Cisplatin; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002694751,0.0007444935,0.002012695,0.0004416142,0.000250924,0.000734519,0.0004263249,0.000574379,0.001311745],"category_scores_gemma":[0.002238141,0.0003069016,0.003692542,0.0005857305,0.000400771,0.0004946667,0.0004360743,0.000951033,0.000157689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005625496,"about_ca_system_score_gemma":0.0006663767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005692418,"about_ca_topic_score_gemma":0.001639153,"domain_scores_codex":[0.9990839,0.0004671146,0.0001624075,0.0001452716,0.00007913908,0.00006218343],"domain_scores_gemma":[0.9988207,0.0004050871,0.0003213077,0.0001616193,0.00007674006,0.0002143858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7704824,0.003373543,0.1334077,0.001780549,0.03099691,0.0004056179,0.0003672755,0.00160915,0.01151436,0.0001065136,0.0006620009,0.04529414],"study_design_scores_gemma":[0.2255231,0.1946807,0.5002638,0.0002147188,0.06390829,0.001530354,0.0004937517,0.004099729,0.005850047,0.0004446835,0.00288848,0.0001023162],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967194,0.002359623,0.0001691429,0.00006624452,0.00002799149,0.0002244302,0.0002225731,0.000006233744,0.0002042223],"genre_scores_gemma":[0.9982023,0.0007482972,0.0002117673,0.0001284595,0.00004333237,0.0001471933,0.0003858798,0.000004656581,0.0001281066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002694751,"threshold_uncertainty_score":0.01425141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07379111199909638,"score_gpt":0.4749157271630475,"score_spread":0.4011246151639511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}